PressMarch 28, 2024 Filament Health Announces Appointment of Michael Messinger To Its Board of Directors
Market ResearchMarch 27, 2024 Preparing for the Horizons: Perspectives on Psychedelics Event in New York
Market ResearchMarch 27, 2024 atai Life Sciences Applauds Breakthrough in Depression Treatment with Beckley Psytech’s DMT Study
PressMarch 27, 2024 Beckley Psytech announces positive initial data from Phase IIa study of novel 5-MeO-DMT formulation BPL-003 for Treatment Resistant Depression
PressMarch 26, 2024 Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
PressMarch 26, 2024 Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
PressMarch 20, 2024 MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder
PressMarch 20, 2024 Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
PressMarch 20, 2024 Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
PressMarch 19, 2024 Filament Health Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation
PressMarch 19, 2024 Breakthrough in Wellness: Clearmind Medicine’s Psychedelic Treatment Granted Divisional Patent Approval in China
PressMarch 18, 2024 Red Light Holland Announces Happy Caps Mushroom Home Grow Kits Now Available in Over 270 Retail Stores Across Canada
PressMarch 18, 2024 Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
